When it comes to cancer care, precision isn rsquo;t a luxury mdash;it rsquo;s an essential aspect of the treatment .

A robotic prostatectomy surgery was performed remotely from Florida on a patient in Angola as part of an FDA-approved ...

Stay informed with the latest breaking news from Afghanistan. Politics, business, sports, and culture updates in English – ...

Another Day Pharma Ltd, a company developing innovative therapies for sexual dysfunction in both men and women, today announced Phase II results for its new treatment BZ371A in post-prostatectomy ...

With today’s advanced treatments, from robotic prostatectomy to targeted radiation to advances in hormone treatments, there is no reason not to know that an 82-year-old president has prostate ...

The first patient has been enrolled in the pivotal ARID II (A Pivotal Study of VoRo UrologIc ScaffolD for the Treatment of Post Prostatectomy Stress Urinary Incontinence) trial that is looking to ...

Safety: The rates of grade 3 or higher complications (3.7% prostatectomy, 1.9% nephrectomy, and 17.9% cystectomy) were favorably below the performance goals (20% prostatectomy, 20% nephrectomy ...

The first patient has been enrolled in the pivotal phase 3 ARID II trial (NCT06873581), evaluating the safety and effectiveness of the Voro Urologic Scaffold in managing post-prostatectomy stress ...

3D modeling for robotic prostatectomy Cost comparison of checkpoint inhibitors in high-risk bladder cancer AI-generated prostate cancer mapping A wearable optical system for bladder monitoring ...

A retrospective analysis was conducted on 50 patients with large-volume (> 100 ml) prostate cancer who underwent robotic radical prostatectomy from June 2020 to August 2023. Patient ages ranged from ...

The Cambridge, U.K.-based company said this milestone solidifies its position as the second most-used soft-tissue surgical robot on the market. “We are proud that over 30,000 patients around the world ...

The world's first dual-robotic prostate removal was performed last month in Texas. This novel approach aims to reduce the risk of erectile dysfunction that accompanies prostate cancer.